Waddill William D. - Insider Non-Derivative Transactions at ARROWHEAD PHARMACEUTICALS, INC. (ARWR) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 19, 2025, Waddill William D.'s relationship to ARROWHEAD PHARMACEUTICALS, INC. (ARWR) is Director, and currently has 62,514 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ARWR insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Waddill William D. - Insider Non-Derivative Transactions of ARWR Common Stock

Waddill William D. - Insider Non-Derivative Transactions at ARWR

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 20, 2025	Sell -- (Common Stock)	500	68.53	56563
Dec 20, 2025	Sell -- (Common Stock)	5451	68.01	57063
Dec 20, 2025	Sell -- (Common Stock)	2416	66.66	62514
Dec 17, 2025	Acquisition -- (Common Stock)	7819	0	64930
Dec 19, 2024	Acquisition -- (Common Stock)	16733	22.99	57111
Dec 18, 2024	Sell -- (Common Stock)	3747	22.04	40378
Dec 17, 2024	Sell -- (Common Stock)	3748	21.9	44125
Jan 12, 2024	Sell -- (Common Stock)	1300	38.59	47870
Jan 12, 2024	Sell -- (Common Stock)	2634	37.81	49170
Dec 16, 2023	Acquisition -- (Common Stock)	14987	25.41	51804
Jan 11, 2023	Acquisition -- (Common Stock)	7867	0	36817
Jan 10, 2023	Sell -- (Common Stock)	3200	30	28950